Cutera (CUTR) Postponing TruSculpt Body Contouring Product Release
Up)
Cutera, Inc. (NASDAQ: CUTR) announced today that it is postponing indefinitely the release of its TruSculpt body contouring product.
Kevin Connors, CEO commented, "We have had the opportunity to review recent clinical data from our research and have determined that established clinical protocols have not yielded the desired outcome. We believe the potential market for non-invasive body contouring is very large; however, our standards for product performance are higher than is commercially available. We have a strong history of introducing leading products with a high level of clinical efficacy that ensure customer success."
He concluded, "We will continue our research efforts, including the monitoring of our clinical sites, and will commercialize the technology, if and when it has met the standards our customers have come to expect from us. This decision will allow us to redirect some of our resources on other exciting development projects."
Kevin Connors, CEO commented, "We have had the opportunity to review recent clinical data from our research and have determined that established clinical protocols have not yielded the desired outcome. We believe the potential market for non-invasive body contouring is very large; however, our standards for product performance are higher than is commercially available. We have a strong history of introducing leading products with a high level of clinical efficacy that ensure customer success."
He concluded, "We will continue our research efforts, including the monitoring of our clinical sites, and will commercialize the technology, if and when it has met the standards our customers have come to expect from us. This decision will allow us to redirect some of our resources on other exciting development projects."
You May Also Be Interested In
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- BlackRock (BLK) Substantially Boosts Stake in Chesapeake (CHK) -CNBC's Kelly
- Dow Chemical (DOW) Wins $2.16B in K-Dow Arbitration
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
